2. 您的位置
3. 首页
4. 会议论文
5. Management of major depressive disorder after an inadequate response to first-line treatment

Management of major depressive disorder after an inadequate response to first-line treatment

来源 :中华医学会第十一次全国精神医学学术会议暨第三届亚洲神经精神药理学术会议 | 被引量 : 0次 | 上传用户：abc1234Shi

【摘 要】

：

Thirty to 50％ of people with major depressive disorder do not respond (or partial respond) to the usual recommended dose of first line antidepressants.The following strategies should be adopted for ma

【作 者】

：

Chia-Yih Liu 

【机 构】

：

Department of Psychiatry,Chang Gung Medical Center at Linkou Department of Psychiatry,Chang Gung Uni

【出 处】

：

中华医学会第十一次全国精神医学学术会议暨第三届亚洲神经精神药理学术会议

【发表日期】

：

2013年12期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

Thirty to 50％ of people with major depressive disorder do not respond (or partial respond) to the usual recommended dose of first line antidepressants.The following strategies should be adopted for managing treatment resistant depression:[Step 1].Re-evaluation of the diagnosis.

其他文献

A self-reported survey on sleep problems in Chinese illicit drug abusers:comparison with non-drug-us

Aims This cross-sectional study explored sleep quality in illicit drug abuse subjects in China.Design,setting,and measurements 1537 illicit drug abuse subjects from drug rehabilitation centres (Hunan

会议

A 12-week randomized,double-blind,placebo-controlled multicenter clinical trial of acamprosate for t

Objective To evaluate the efficacy and safety of acamprosate in treating patients with alcohol dependence.

会议

Distribution of disability attributable to mental and behavioral disorders due to psychoactive subst

Objective In order to provide evidence for making strategy and measurement related to disability rehabilitation,prevalence of disability attributable to mental and behavioral disorders due to psychoac

会议

A comparative study of Addition therapy of Choline Alfoscerate and omega 3 fatty acid in older depre

TheDepression Executive Dysfunction Syndromeafflicts a considerable number of depressed elderly patients and may be resistant to conventional pharmacotherapy.We studied the Choline Alfoscerate or the

会议

Escitalopram in the acute treatment of severe depression:a single-arm,open-label multicenter trial i

OBJECTIVE:The aim of this study was to evaluate the efficacy and safety of escitalopram on treatment of severe Major Depressive Disorder (MDD) subjects in China METHODS This was an 8-week,single arm,o

会议

Escitalopram in long-term treatment of major depressive disorder with associated anxiety symptoms:a

OBJECTIVE The aim of the study was to evaluate the efficacy and safety of long term escitalopram treatment in Major Depressive Disorder (MDD) in Chinese patients with associated anxiety symptoms and a

会议

An Observational Study to Evaluate the Clinical Benefit of Lamotrigine Add-on Therapy in Bipolar Pat

Objective The objective of the current study was to assess the clinical benefit of lamotrigine add-on in patients with bipolar disorder in a naturalistic treatment setting.

会议

Sertraline and periodic limb movement during sleep:an 8-week,open-label study in depressed patients

Previous studies have reported that selective serotonin reuptake inhibitors (SSRIs) might induce or exacerbate periodic limb movement during sleep (PLMS).However,most of them were retrospective and cr

会议

One-year rehospitalization rates in patients with first-episode bipolar mania on lithium and valproa

Objective:We compared the one-year rehospitalization rates of first-episode bipolar manic patients who were discharged while being treated with lithium or valproate in combination with an atypical ant

会议

Effectiveness of duloxetine monotherapy compared to combination therapy with other antidepressants i

Objective Duloxetine is an antidepressant that effects a serotonergic and noradrenergie neurotransmitter,and a useful agent in the treatment of the patients with anxiety or depressive disorders.Accord

会议